Precision medicine has greatly aided in improving health outcomes using earlier diagnosis
and better prognosis for chronic diseases. It makes use of clinical data associated with the …

Atrial fibrillation (AF) and heart failure (HF) contribute to about 45% of all cardiovascular
disease (CVD) deaths in the USA and around the globe. Due to the complex nature …

Cardiovascular disease (CVD) is the leading cause of mortality and loss of disability
adjusted life years (DALYs) globally. CVDs like Heart Failure (HF) and Atrial Fibrillation (AF) …

Cardiovascular disease (CVD) is caused by a multitude of complex and largely heritable
conditions. Identifying key genes and understanding their susceptibility to CVD in the human …

Personalized interventions are deemed vital given the intricate characteristics,
advancement, inherent genetic composition, and diversity of cardiovascular diseases …

Diagnostics require precision and predictive ability to be clinically useful. Integration of multi-
omic with clinical data is crucial to our understanding of disease pathogenesis and …

The quest to understand what causes chronic, acute, infectious, and rare diseases has been
a central focus of human health studies since the beginning of scientific discovery (Ahmed …

Due to the advancements in sequencing technologies, genomics data is developing at an
unmatched pace and levels to foster translational research. Over ten million genomics …

Chronic obstructive pulmonary disease (COPD) can be prevented and treated through
effective care, reducing exacerbations and hospitalizations. Early identification of individuals …

Synthetic antibodies (Abs) represent a category of artificial proteins capable of closely
emulating the functions of natural Abs. Their in vitro production eliminates the need for an …